Skip to main content
SpringerLink
Log in

Nebennierenrindentumoren

  • Übersichten
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Adrenokortikale Tumoren sind von Rindenhyperplasien, Marktumoren und extraadrenalen Tumoren bzw. Metastasen zu unterscheiden, meistens in der Paraffinschnitt-Histologie, gelegentlich mit zusätzlichen immunhistologischen Analysen. Die Nebennierenrindenhyperplasien können inaktiv sein oder mit Überfunktionssyndromen einhergehen. Als Sonderform ist die primäre pigmentierte adrenokortikale noduläre Erkrankung als primär adrenale Form des Cushing-Syndroms abzugrenzen. Nebennierenrindenadenome sind fast immer unilateral, solitär und unter 50 g schwer. Nebennierenrindenkarzinome sind meistens deutlich größer. Wie die Adenome können sie inaktiv sein oder einen Hyperkortisolismus, Hyperandrogenismus oder bei Karzinomen sehr selten einen Hyperaldosteronismus hervorrufen. Für die Differenzialdiagnose zwischen Rindenadenomen und Rindenkarzinomen steht ein diagnostischer Algorithmus zur Verfügung. Myelolipome sind immer gutartige und inaktive Tumoren. Sie sind von Adenomen mit myelolipomatöser Metaplasie zu unterscheiden. Auf weitere seltene primäre Rindentumoren wird kurz eingegangen.

Abstract

Adrenocortical tumours have to be differentiated from cortical hyperplasias, medullary tumours and extra-adrenal tumours or metastases. These diagnoses are mostly possible using routine paraffin sections. In some cases, immunostaining for differing cortical and medullary tumours and metastases are necessary. Adrenal hyperplasias can be congenital or acquired. They are diffuse, micronodular or macronodular and may be inactive or induce a cortical hyperfunction. Very rarely, macronodular hyperplasias may transform into autonomous adenomas. Primary, pigmented adrenocortical disease is a rare, special type of primary adrenal Cushing's syndrome, showing many small tumours with pleomophic cells and an atrophic surrounding cortical tissue. Adrenal adenomas are mostly unilateral and solitary tumours weighing less than 50 g. Adrenal cortical carcinomas are mostly larger. Like the adenomas, they may be inactive and may induce a hypercortisolism, a hyperandrogenism or (very rarely in carcinomas) a hyperaldosteronism. Differentiating cortical adenomas and carcinomas is difficult in some cases but is possible using a diagnostic algorithm. Myelolipomas are benign, inactive tumours composed of mature fat cells and bone marrow cells. They have to be differentiated from adenomas with myelolipomatous metaplasia. Further, rare primary cortical tumours are mentioned.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1.
Abb. 2.
Abb. 3.
Abb. 4.
Abb. 5.
Abb. 6.
Abb. 7.
Abb. 8.

Literatur

  1. Boudreau D, Waisman J, Skinner D, Low R (1979) Giant adrenal myelolipoma and testicular interstitial cell tumor in a man with congenital 21-hydrxylase deficiency. Am J Surg Pathol 3: 109–123

    PubMed  Google Scholar 

  2. Corsi A, Riminucci M, Petrozza V et al. (2002) Incidentally detected giant oncocytoma arising in retroperitoneal heterotopic adrenal tissue. Arch Pathol Lab Med 126: 1118–1122

    PubMed  Google Scholar 

  3. Dhom G (1981) Die Nebennierenrinde. In: Doerr W, Seifert G (Hrsg) Pathologie der endokrinen Organe, Teil II. Springer, Berlin Heidelberg New York, S 729–970

  4. El-Naggar AK, Evans DB, Mackay B (1991) Oncocytic adrenal cortical carcinoma. Ultrastruct Pathol 15: 549–556

    CAS  PubMed  Google Scholar 

  5. Fogt F, Vortmeyer AO, Poremba C et al. (1998) bcl-2 expression in normal adrenal glands and in adrenal neoplasms. Mod Pathol 11: 716–720

    CAS  PubMed  Google Scholar 

  6. Hough AJ, Hollifield JW, Page DL, Hartmann WH (1979) Prognostic factors in adrenal cortical tumours. Am J Clin Pathol 72: 390–399

    CAS  PubMed  Google Scholar 

  7. Iino K, Sasano H, Yabuki N, Oki Y, Kikuchi A, Yoshimi T, Nagura H (1997) DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas. Mod Pathol 10: 901–907

    CAS  PubMed  Google Scholar 

  8. Lack EE (1997) Pathology of the adrenal cortex. In: Lechago J, Gould VE (eds) Bloodworth's endocrine pathology. Williams & Wilkens, Baltimore, pp 355–416

  9. Lack EE (1997) Tumors of the adrenal gland and extra-adrenal paraganglia. Atlas of tumor pathology. Armed Forces Institute of Pathology, Washington/DC

  10. Lack EE (1998) The adrenal cortex. In: Kovacs K, Asa SL (eds) Functional endocrine pathology. Blackwell Science, Malden, pp 596–636

  11. Lloyd RV, Douglas BR, Young WF Jr (2002) Adrenal gland. In: de Lellis RA, LiVolsi VA (eds) Endocrine diseases. Armed Forces Institute of Pathology, Washington/DC, pp 171–258

  12. Mitschke H, Saeger W, Breustedt HJ (1978) Feminizing adrenocortical tumor. Histological and ultrastructural study. Virchows Arch Path Anat 377: 301–309

    CAS  Google Scholar 

  13. Nakazumi H, Sasano H, Iino K, Ohashi Y, Orikasa S (1998) Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. Mod Pathol 11: 1165–1170

    CAS  PubMed  Google Scholar 

  14. Neville AM, O'Hare MJ (1982) The human adrenal cortex. Springer, Berlin Heidelberg New York

  15. Pelkey TJ, Frierson HF, Mills SE, Stoler MH (1998) The alpha subunit of inhibin in adrenal cortical neoplasia. Mod Pathol 11: 516–524

    CAS  PubMed  Google Scholar 

  16. Röher H-D, Klempa I, Simon D et al. (2000) Leitlinien zur chirurgischen Therapie von Nebennierenerkrankungen. Mitteil Dtsch Ges Chir 1–12

  17. Saeger W (1995) Pathology of adrenal neoplasms. Minerva Endocrinol 20: 1–8

    CAS  Google Scholar 

  18. Saeger W (1996) Critical commentary to "Adrenal cortical adenoma with extensive fat cell metaplasia". Path Res Pract 192: 66

    Google Scholar 

  19. Saeger W, Fassnacht MC, Chita R et al. (2003) High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian Adrenal Network multicenter trial in 220 consecutive patients. Hum Pathol 34: 180–186

    Google Scholar 

  20. Saeger W, Fassnacht MC, Reincke M, Allolio B (2002) Expression of HER-2/neu receptor protein in adrenal tumors. Path Res Pract 198: 445–448

    CAS  PubMed  Google Scholar 

  21. Saeger W, Reinhard K (1998) Fat cell metaplasia in the adrenal cortex: Incidence, structure and correlation to basic diseases in a postmortem series. Endocr Pathol 9: 241–248

    PubMed  Google Scholar 

  22. Saeger W, Reinhard K, Reinhard C (1998) Hyperplastic and tumorous lesions of the adrenals in an unselected autopsy series. Endocr Pathol 9: 235–239

    PubMed  Google Scholar 

  23. Saeger W, Schröder S, Klöppel G (2001) Pathologie wichtiger Erkrankrungen endokriner Organe (Schilddrüse ausgenommen). Pathologe 22: 296–309

    Article  CAS  PubMed  Google Scholar 

  24. Samuels MH, Loriaux DL (1994) Cushing's syndrome and the nodular adrenal gland. Endocrinol Metab Clin N Am 23: 555–569

    CAS  Google Scholar 

  25. Sasano H (2000) The adrenal cortex, In: Stefaneanu L, Sasano H, Kovacs K (eds) Molecular and cellular endocrine pathology. Arnold, London, pp 221–252

  26. Sasano H, Miyazaki S, Sawai T et al. (1992) Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. Mod Pathol 5: 23–29

    CAS  PubMed  Google Scholar 

  27. Smals AGH, Peters GFFM, van Haelst UJG, Kloppenborg P (1984) Macronodular adrenocortical hyperplasia in long-standing Cushing's disease. J Clin Endocrinol Metab 58: 25–31

    CAS  PubMed  Google Scholar 

  28. Solcia E, Klöppel G, Sobin LH et al. (2000) Histological typing of endocrine tumours. Springer, Berlin Heidelberg New York Tokio

  29. Stein SH, Latour F, Frost SS (1986) Myelolipoma arising from ectopic adrenal cortex: case report and review of the literature. Gastroenterology 81: 999–1001

    CAS  Google Scholar 

  30. van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ (1985) Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55: 766–773

    PubMed  Google Scholar 

  31. Weiss LM (1984) Comparative histologic study of 43 metastasizing and non-metastasizing adrenocortical tumors. Am J Surg Pathol 8: 163–169

    CAS  PubMed  Google Scholar 

  32. Weiss LM, Medeiros LJ, Vickery AL (1989) Pathologic features of prognostic significance in adrenal cortical carcinoma. Am J Surg Pathol 13: 202–206

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pathologie des Marienkrankenhauses, Hamburg

    W. Saeger

  2. Institut für Pathologie des Marienkrankenhauses, Hamburg, Alfredstraße 9, 22087, Hamburg

    W. Saeger

Authors
  1. W. Saeger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Saeger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saeger, W. Nebennierenrindentumoren. Pathologe 24, 272–279 (2003). https://doi.org/10.1007/s00292-003-0621-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-003-0621-1

Schlüsselwörter

Keywords

Search

Navigation